Digital pathology is of pathology focuses on data management based on information generated from digitized specimen slides. The field of digital pathology and evaluation of digital whole slide images (WSI) has seen incredible growth in recent years. Digital pathology addresses the limitations of traditional pathology workflows in many ways. Digitization help labs to increase caseloads, streamline processes, increase organization, and reduce turnaround time. Through the use of computer-based technology, digital pathology uses virtual microscopy. Glass slides are converted into digital slides and then can be viewed, shared, managed, and analyzed on a computer monitor. It is the practice of pathology using digital imaging. Digital pathology is, by now, indisputably the future of the field.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/379
Major players operating in the global digital pathology market are 3D-Histech Ltd., Ventana Medical Systems, Inc., Inspirata Co., Leica Biosystems, GE Healthcare, Paige, Koninklijke Philips N.V., Sectra ABss, Definiens AG, Perkin Elmer, Inc., and Hamamatsu Photonics, K.K.
Key Market Drivers:
Rising incidence of chronic diseases, such as cancer, worldwide and need for early diagnosis of such conditions is expected to propel the growth of the digital pathology market during the forecast period. For instance, according to the World Health Organization (WHO), chronic disease prevalence is expected to rise by 57% by the year 2020. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.
Moreover, growing application of digital pathology in the healthcare is expected to aid in the growth of the digital pathology market. For instance, in January 2021, Roche announced the CE-IVD launch of its two automated digital pathology algorithms, such as uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis, for breast cancer to help determine the best treatment strategy for each patient.
COVID-19 Impact Analysis:
The outbreak of COVID-19 has a profound impact on routine pathology services. While, digital pathology can play a vital role ‘to safeguard clinical services and pathology-based research in the current climate and in the future’. Digital pathology has been hailed as a potential solution to at least some of the challenges faced. Moreover, the pandemic has fueled interest in digital pathology, given that the need for pathologists to review and report pathology is critical to the continuum of patient care, and to protect health professionals or workers safety is important to ensure uninterrupted, expert pathology practice. This in turn is expected to augment the growth of the digital pathology market, worldwide.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/379
- The digital pathology market is expected to exhibit a CAGR of XX % during the forecast period owing to the introduction of novel, advanced digital pathology platform/devices in the global market. For instance, in June 2020, Roche announced the CE-IVD launch of its automated digital pathology platform, uPath PD-L1 (SP263), for non-small cell lung cancer (NSCLC). The new platform uses artificial intelligence (AI) to easily provide pathologists with automated assessments of scanned slide images that are reproducible and can aid diagnosis and target treatment options for patients.
- Among regions, North America and Asia Pacific are expected to witness robust growth in the digital pathology market, owing to the increasing prevalence of cancer, rise in adoption of digital pathology in the healthcare industry, increasing clinical and preclinical trials, and integration of cloud in digital pathology. For instance, according to the American Cancer Society, in 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the U.S. Moreover, September 2021, Indica Labs announced the formal launch of its cloud-based digital pathology software to manage millions of digital images and facilitate the analysis of thousands of images daily.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027